Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

BACKGROUND: The purpose of this study was to investigate the suitability of nanostructured lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment of breast cancer. METHODS: HePC-NLCs were prepared using a microemulsion technique and then evaluated for particle s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guo, Ali, Zakir, Sajjad Khan, Anam, Ullah, Kalim, Jamshaid, Humzah, Zeb, Alam, Imran, Muhammad, Sarwar, Sadia, Choi, Han-Gon, ud Din, Fakhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127833/
https://www.ncbi.nlm.nih.gov/pubmed/34012260
http://dx.doi.org/10.2147/IJN.S299443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127833/
https://www.ncbi.nlm.nih.gov/pubmed/34012260
http://dx.doi.org/10.2147/IJN.S299443

Ejemplares similares